Quantcast

Contract Research Organization, WCCT Global, Announces Cutting Edge Special Population Recruitment Management Tool

February 25, 2013

WCCT Global has developed a cutting edge special population recruitment tool for clinical studies.

Costa Mesa, California (PRWEB) February 25, 2013

WCCT Global, a contract research organization (CRO) supporting Phase I – IV biopharmaceutical and medical device development, announces today the rollout of their innovative special population Recruitment Management Tool (RMT)for early and late phase clinical studies. Recruiting the right participants into a clinical trial is a fundamental and essential element for success that easily gets overlooked. WCCT Global has built a cutting edge recruitment tool in order to meet the needs of sponsors who have studies either competitively or non-competitively recruiting in any region of the country.

The WCCT Global RMT consists of a proprietary algorithm which combines multiple web technologies which enables recruiters to target specific patients needed for any project. Any geographic region or diagnostic category can be targeted. The recruiters can be centrally located while recruiting nationally, thus, using less resources and shortening overall recruitment times.

Lee Barsky, Vice President of Program Management said, “I truly believe our new recruitment tool is raising the bar for all Contract Research Organization´s recruitment efforts. We are now able to precisely target the required resources to recruit specific patient populations anywhere in the US in record time.” WCCT Global has been able to successfully screen and randomize multiple special population clinical studies including Asian-bridging studies, difficult asthma studies, ophthalmology studies, and infectious disease studies using this recruitment management tool and feels it is a must have for every clinical trial.

More about WCCT Global:

WCCT Global is a multi-site, full service contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow´s therapies to be available today” truly exemplifies the focus and reason for our cutting edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.

If you would like to see how the WCCT Global Recruitment Management Tool (RMT) can successfully enroll for your study, CLICK HERE.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/2/prweb10460587.htm


Source: prweb



comments powered by Disqus